Publish Date
30 Nov -0001
Abstract. Medicinal plants with hypoglycemic properties have long been used in traditional medicine for managing diabetes mellitus, although scientific evidence regarding their efficacy and mechanisms of action remains limited. Muntingia calabura L. (kersen) is a medicinal plant known to contain bioactive compounds with antioxidant and glucose-lowering potential. This study aimed to evaluate the antihyperglycemic effect of M. calabura leaf extract and its ability to repair damage to the pancreatic islets of Langerhans in hyperglycemic mice. A total of 24 male white mice (Mus musculus L.) were randomly divided into six groups: a normal control group, an alloxan-induced hyperglycemic control group, an alloxan plus glibenclamide group, and three treatment groups receiving kersen leaf extract at doses of 200, 400, and 800 mg/kg body weight, respectively. Hyperglycemia was induced using alloxan at a dose of 160 mg/kg body weight, and the extract was administered orally for 14 consecutive days. Blood glucose levels were measured, and pancreatic tissues were examined histologically to assess morphological changes in the islets of Langerhans. The results showed that mice treated with kersen leaf extract exhibited a significant reduction in blood glucose levels compared with the hyperglycemic control group (p<0.05). Histological analysis revealed substantial restoration of pancreatic architecture, characterized by increased islet size and β-cell density resembling those of normal mice. These findings suggest that kersen leaf extract possesses potent antihyperglycemic and β-cell regenerative properties, supporting its potential as a natural candidate for antidiabetic therapy.
Copyrights © 0000